Clinical Trials Directory

Trials / Completed

CompletedNCT00380354

Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma

A Two-centre, Randomised, Double-blind, Placebo-controlled, 2-period Cross-over Study to Evaluate the Effect of Treatment With Repeat Doses of Inhaled GSK256066 on the Allergen-induced Late Asthmatic Response in Subjects With Mild Asthma

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
11 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the efficacy and safety of GSK256066 in the treatment of subjects with mild bronchial asthma, using a number of clinical and biological markers of efficacy.

Conditions

Interventions

TypeNameDescription
DRUGGSK256066

Timeline

Start date
2006-09-01
Completion
2007-06-01
First posted
2006-09-25
Last updated
2012-06-04

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00380354. Inclusion in this directory is not an endorsement.